An injectable multifunctional hydrogel for targeted microenvironment regulation in diabetic meibomian gland dysfunction

Diabetic meibomian gland dysfunction (MGD) is associated with duct obstruction, excessive oxidative stress, chronic inflammation, and disturbed lipid metabolism, which together contribute to progressive gland dysfunction. These interconnected abnormalities make it difficult to achieve effective treatment by targeting a single pathological process. Here, we developed an injectable multifunctional hydrogel for diabetic MGD treatment by integrating complementary therapeutic functions into a thermosensitive PLGA-PEG-PLGA matrix. Dexamethasone (Dex)-loaded mesoporous polydopamine nanoparticles (Dex@mPDA) were incorporated into the hydrogel to provide photothermal, antioxidative, and anti-inflammatory functions. After local administration, the hydrogel formed an in situ depot around the meibomian glands. Upon near-infrared irradiation, mPDA generated mild photothermal heating to liquefy obstructed meibum, while its ROS-scavenging activity reduced oxidative stress and locally delivered Dex suppressed chronic inflammation, thereby remodeling the pathological microenvironment of diabetic MGD. In vitro and in vivo studies demonstrated that the hydrogel reduced the oxidative stress-inflammation cycle, promoted meibocyte differentiation and lipid synthesis, and restored meibomian gland function. In diabetic MGD mice, treatment relieved gland obstruction, preserved gland morphology, restored lipid metabolic homeostasis, and improved tear film stability. Collectively, the injectable hydrogel provides a pathology-guided therapeutic strategy for diabetic MGD and highlights the potential of pathology-guided biomaterial design for treating chronic ocular surface diseases.

Authors

Institutions

Publication Details

Journal
Bioactive Materials
Published
2026-11-19
DOI
https://doi.org/10.1016/j.bioactmat.2026.11.015
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An injectable multifunctional hydrogel for targeted microenvironment regulation in diabetic meibomian gland dysfunction

Dewei Li, Xinyu Wang, Yanlin Zhong, Jingyu Qu et al.
Bioactive Materials
Ocular Surface and Contact Lens
article

An injectable multifunctional hydrogel for targeted microenvironment regulation in diabetic meibomian gland dysfunction

Dewei Li, Xinyu Wang, Yanlin Zhong, Jingyu Qu, Qihang Wang, Qingjun Zhou, Lixin Xie, Xue Li, Hengrui Zhang
article en

Abstract

Diabetic meibomian gland dysfunction (MGD) is associated with duct obstruction, excessive oxidative stress, chronic inflammation, and disturbed lipid metabolism, which together contribute to progressive gland dysfunction. These interconnected abnormalities make it difficult to achieve effective treatment by targeting a single pathological process. Here, we developed an injectable multifunctional hydrogel for diabetic MGD treatment by integrating complementary therapeutic functions into a thermosensitive PLGA-PEG-PLGA matrix. Dexamethasone (Dex)-loaded mesoporous polydopamine nanoparticles (Dex@mPDA) were incorporated into the hydrogel to provide photothermal, antioxidative, and anti-inflammatory functions. After local administration, the hydrogel formed an in situ depot around the meibomian glands. Upon near-infrared irradiation, mPDA generated mild photothermal heating to liquefy obstructed meibum, while its ROS-scavenging activity reduced oxidative stress and locally delivered Dex suppressed chronic inflammation, thereby remodeling the pathological microenvironment of diabetic MGD. In vitro and in vivo studies demonstrated that the hydrogel reduced the oxidative stress-inflammation cycle, promoted meibocyte differentiation and lipid synthesis, and restored meibomian gland function. In diabetic MGD mice, treatment relieved gland obstruction, preserved gland morphology, restored lipid metabolic homeostasis, and improved tear film stability. Collectively, the injectable hydrogel provides a pathology-guided therapeutic strategy for diabetic MGD and highlights the potential of pathology-guided biomaterial design for treating chronic ocular surface diseases.

Bioactive MaterialsVol. 70
Shandong First Medical University (CN)
Ocular Surface and Contact Lens
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon